Canada Markets close in 3 hrs 53 mins

Sanofi (SNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.53-1.67 (-3.69%)
As of 12:06PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close45.20
Open42.02
Bid44.07 x 900
Ask44.07 x 1000
Day's Range41.91 - 44.09
52 Week Range41.91 - 58.10
Volume15,658,799
Avg. Volume2,303,869
Market Cap109.414B
Beta (5Y Monthly)0.36
PE Ratio (TTM)15.62
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.75 (3.51%)
Ex-Dividend DateMay 26, 2022
1y Target EstN/A
  • GlobeNewswire

    Sanofi: Information concerning the total number of voting rights and shares – July 2022

    Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,534,952,234 €Registered office : 54, rue La Boétie - 75008 Paris - FranceRegistered at the Paris Commercial and Companies Registry under n

  • GlobeNewswire

    Press Release: Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China

    Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China Collaboration to accelerate the development and access of oncology medicines for cancer patients in ChinaClinical trial programs combining two of Sanofi’s prioritized oncology assets with sintilimab, the leading checkpoint inhibitor in China, to address some of the most prevalent solid tumors in China Sanofi to make an initial equity investment of €300 million

  • GlobeNewswire

    Press Release: Online availability of Sanofi’s half-year financial report for 2022

    Online availability of Sanofi’s half-year financial report for 2022 Paris, July 28, 2022. Sanofi announces that its half-year financial report for the period ending June 30, 2022 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K. This document may be found on the company’s corporate website: www.sanofi.com and downloaded from the “Investors” page, under the h